Form 4: Cardinal Health CEO Sells Shares, Receives RSU Grant

Cardinal Health CEO Jason M. Hollar reported the sale of over 100,000 common shares following a significant RSU grant and tax-related share withholding.

Summary

• Jason M. Hollar, Chief Executive Officer of Cardinal Health Inc. (CAH), reported several transactions involving the company's common shares.
• On August 15, 2025, Mr. Hollar acquired 42,778 common shares through a grant of restricted share units (RSUs) at a price of $0. These RSUs are scheduled to vest in three equal annual installments beginning on August 15, 2026.
• Also on August 15, 2025, 136,407 common shares were disposed of at a price of $150.22. This disposition was to satisfy tax withholding obligations related to the vesting of 61,869 RSUs and 245,420 performance share units.
• On August 19, 2025, Mr. Hollar sold a total of 107,705 common shares across three separate transactions:
• 6,657 shares were sold at a weighted average price of $148.15, with prices ranging from $147.40 to $148.39.
• 94,735 shares were sold at a weighted average price of $148.92, with prices ranging from $148.40 to $149.39.
• 6,313 shares were sold at a weighted average price of $149.45, with prices ranging from $149.40 to $149.58.
• All reported transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
• Following these transactions, Mr. Hollar's direct beneficial ownership of common shares stands at 235,901.

Sentiment

Score: 6

Explanation: The filing reports both a grant of restricted share units and significant sales of common shares by the CEO. While the sales reduce the CEO's direct holdings, they were conducted under a pre-arranged 10b5-1 plan and included substantial tax-related withholdings, which is a common practice for executive compensation. This suggests a neutral to slightly positive sentiment, as the RSU grant aligns interests and the sales are routine.

Positives

• The grant of 42,778 restricted share units (RSUs) to the CEO aligns his long-term interests with shareholder value, as these units vest over three years.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-scheduled sales and reducing concerns about opportunistic insider trading.

Negatives

• The CEO disposed of a significant number of shares (136,407 for tax withholding and 107,705 through sales), reducing his direct beneficial ownership.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the vesting schedule for the granted restricted share units.

Industry Context

This Form 4 filing details routine insider transactions by a key executive in the healthcare services and products industry. Such transactions are common for executives managing their compensation and liquidity, and do not inherently reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders may observe a reduction in the CEO's direct share ownership, which could be interpreted in various ways, though the 10b5-1 plan and tax-related dispositions mitigate concerns.
• The RSU grant reinforces the CEO's long-term incentive alignment with the company's performance.

Next Steps

• The granted restricted share units (RSUs) will begin to vest in three equal annual installments starting on August 15, 2026.

Key Dates

Recommendation

The filing details routine insider transactions, including a grant of equity awards and subsequent sales, largely for tax purposes and under a pre-arranged plan. While the sales reduce the CEO's direct ownership, they do not necessarily signal a change in the company's fundamental outlook or the CEO's confidence. Investors should consider these transactions as part of standard executive compensation and liquidity management rather than a bearish signal, maintaining a 'hold' position based solely on this filing.

Keywords

Cardinal Health, CAH, Jason M. Hollar, CEO, Insider Trading, Form 4, Stock Sale, RSU, Restricted Share Units, Executive Compensation, Share Disposition